Editorial
Published on 19 Aug 2024
Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1472463
- 608 views
Type at least 3 characters
1,749 articles
Articles
Case Report
Published on 19 Aug 2024
Case report: A case of effective treatment of primary myelofibrosis with nodular panniculitis using ruxolitinib combined with corticosteroids
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1412021
- 867 views
Mini Review
Published on 15 Aug 2024
Re-examining the role of hematopoietic stem cell transplantation in relapsed large B-cell lymphoma in the era of chimeric antigen receptor (CAR) T-cell therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1397186
- 1,112 views
Mini Review
Published on 08 Aug 2024
Chimeric antigen receptor T-cells: a review on current status and future directions for relapsed/refractory multiple myeloma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1455464
- 2,399 views
Original Research
Published on 07 Aug 2024
Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1433821
- 725 views
Case Report
Published on 05 Aug 2024
Insights into uveitis from Brentuximab vedotin in refractory Hodgkin’s lymphoma: a case report and brief review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1419145
- 834 views
- 1 citation
Review
Published on 02 Aug 2024
MicroRNA dysregulation in myelodysplastic syndromes: implications for diagnosis, prognosis, and therapeutic response
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1410656
- 946 views
Case Report
Published on 01 Aug 2024
Case report: DKRd regimen in the treatment of newly diagnosed POEMS syndrome and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1417380
- 885 views
Case Report
Published on 31 Jul 2024
Case report: An intriguing case of Philadelphia chromosome–positive acute lymphoblastic leukemia recurrence
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1457832
- 978 views
Systematic Review
Published on 31 Jul 2024
Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1362367
- 808 views
Systematic Review
Published on 31 Jul 2024
Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1341631
- 812 views
Review
Published on 29 Jul 2024
Therapeutic options for chronic myeloid leukemia following the failure of second-generation tyrosine kinase inhibitor therapy
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1446517
- 1,574 views
Original Research
Published on 29 Jul 2024
Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1407003
- 1,292 views
Review
Published on 29 Jul 2024
Novel insights and therapeutic approaches in secondary AML
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1400461
- 1,718 views
Review
Published on 26 Jul 2024
The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1414102
- 1,107 views
Review
Published on 24 Jul 2024
Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1382872
- 2,380 views